Sign inGet started

KINGSLEY ALFRED D

Insider CIK 1229339 · NONE Director · OCX Director · BTX See Remarks, Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LCTX Lineage Cell Therapeutics, A Award deriv2023-07-012023-07-0350,000— $050,000SEC↗
OCX Oncocyte Corp A Award deriv2023-06-232023-06-2790,000— $090,000SEC↗
OCX Oncocyte Corp A Award2023-06-232023-06-2720,000— $0489,111SEC↗
OCX Oncocyte Corp P Buy2023-06-142023-06-1530,000$0.21 $6.3K469,111SEC↗
OCX Oncocyte Corp P Buy2022-12-222022-12-2725,000$0.29 $7.2K439,111SEC↗
OCX Oncocyte Corp A Award deriv2022-08-152022-08-1745,000— $045,000SEC↗
OCX Oncocyte Corp P Buy2022-08-152022-08-175,000$0.97 $4.8K409,111SEC↗
OCX Oncocyte Corp P Buy2022-08-152022-08-175,000$0.97 $4.8K414,111SEC↗
OCX Oncocyte Corp A Award2022-08-152022-08-1710,000— $0404,111SEC↗
LCTX Lineage Cell Therapeutics, A Award deriv2022-07-012022-07-0650,000— $050,000SEC↗
OCX Oncocyte Corp M Exercise deriv2022-06-242022-07-1910,000— $00SEC↗
OCX Oncocyte Corp M Exercise2022-06-242022-07-1910,000— $0394,111SEC↗
LCTX Lineage Cell Therapeutics, A Award deriv2021-07-012021-07-0180,000— $080,000SEC↗
OCX OncoCyte Corp A Award deriv2021-06-242021-06-2845,000— $045,000SEC↗
OCX OncoCyte Corp A Award deriv2021-06-242021-06-2810,000— $010,000SEC↗
LCTX Lineage Cell Therapeutics, M Exercise deriv2021-06-222021-06-2361,800— $00SEC↗
LCTX Lineage Cell Therapeutics, M Exercise2021-06-222021-06-2361,800$2.20 $136.0K5,470,245SEC↗
OCX OncoCyte Corp M Exercise deriv2020-12-282020-12-2865,271$1.34 $87.5K0SEC↗
OCX OncoCyte Corp M Exercise2020-12-282020-12-2865,271$1.34 $87.5K384,111SEC↗
OCX OncoCyte Corp M Exercise deriv2020-12-232020-12-281,237$1.34 $1.7K65,271SEC↗
OCX OncoCyte Corp M Exercise2020-12-232020-12-281,237$1.34 $1.7K319,740SEC↗
OCX OncoCyte Corp S Sale2020-12-232020-12-28900$2.55 $2.3K318,840SEC↗
OCX OncoCyte Corp M Exercise deriv2020-12-222020-12-2310,516$1.34 $14.1K66,508SEC↗
OCX OncoCyte Corp M Exercise2020-12-222020-12-2310,516$1.34 $14.1K326,155SEC↗
OCX OncoCyte Corp S Sale2020-12-222020-12-237,652— $0318,503SEC↗
OCX OncoCyte Corp M Exercise deriv2020-12-212020-12-2347,976$1.34 $64.3K77,024SEC↗
OCX OncoCyte Corp S Sale2020-12-212020-12-235,148$2.54 $13.1K315,639SEC↗
OCX OncoCyte Corp S Sale2020-12-212020-12-2330,000— $0320,787SEC↗
OCX OncoCyte Corp M Exercise2020-12-212020-12-2347,976$1.34 $64.3K350,787SEC↗
OCX A Award2020-12-112020-12-155,909— $0302,811SEC↗
LCTX Lineage Cell Therapeutics, A Award deriv2020-07-012020-07-0270,000— $070,000SEC↗
OCX OncoCyte Corp A Award deriv2020-06-172020-06-1957,000— $057,000SEC↗
OCX OncoCyte Corp A Award deriv2019-07-172019-07-1945,000— $045,000SEC↗
BTX BIOTIME INC A Award deriv2019-07-012019-07-0370,000— $070,000SEC↗
BTX BIOTIME INC A Award2019-03-082019-04-056,390— $05,457,945SEC↗
OCX OncoCyte Corp A Award deriv2018-08-302018-09-0445,000— $045,000SEC↗
BTX BIOTIME INC A Award deriv2018-07-012018-07-0370,000— $070,000SEC↗
BTX BIOTIME INC D To issuer2017-08-172017-08-21300,000$2.81 $843.0K5,481,555SEC↗
BTX BIOTIME INC S Sale2017-07-312017-08-02150,000$2.80 $420.0K5,781,555SEC↗
BTX BIOTIME INC A Award deriv2017-07-012017-07-0550,000— $050,000SEC↗
OCX OncoCyte Corp A Award deriv2017-06-152017-06-1950,000— $050,000SEC↗
OCX OncoCyte Corp A Award deriv2017-06-152017-06-1916,300— $016,300SEC↗
BTX BIOTIME INC J Other2017-01-032017-01-06238,469— $01,143,346SEC↗
BTX BIOTIME INC A Award deriv2016-07-012016-07-0550,000— $050,000SEC↗
AST Asterias Biotherapeutics, P Buy2016-06-092016-06-104,000$2.93 $11.7K9,000SEC↗
AST Asterias Biotherapeutics, A Award deriv2016-02-282016-03-0120,000— $020,000SEC↗
OCX OncoCyte Corp A Award deriv2016-02-162016-02-1850,000— $050,000SEC↗
BTX BIOTIME INC S Sale2016-01-202016-01-22300,000$2.35 $705.0K5,638,055SEC↗
BTX BIOTIME INC S Sale2015-11-062015-11-10100,000$3.83 $383.0K5,938,055SEC↗
BTX BIOTIME INC A Award deriv2015-07-012015-07-0650,000— $050,000SEC↗
AST Asterias Biotherapeutics, P Buy2015-06-252015-06-265,000$4.32 $21.6K5,000SEC↗
AST Asterias Biotherapeutics, A Award deriv2015-02-132015-02-1875,000— $075,000SEC↗
BTX BIOTIME INC A Award deriv2014-07-012014-07-0350,000— $050,000SEC↗
BTX BIOTIME INC M Exercise deriv2014-06-272014-07-0150,000— $00SEC↗
BTX BIOTIME INC M Exercise2014-06-272014-07-0150,000$2.30 $115.0K6,038,055SEC↗
BTX BIOTIME INC S Sale2014-05-162014-05-16300,000$2.45 $735.0K5,988,055SEC↗
BTX BIOTIME INC S Sale2014-05-082014-05-09300,000$2.44 $732.0K6,288,055SEC↗
NONE Asterias Biotherapeutics, J Other deriv2014-04-012014-04-0375,000— $075,000SEC↗
BTX BIOTIME INC A Award deriv2013-07-012013-07-0350,000— $050,000SEC↗
BTX BIOTIME INC S Sale deriv2013-06-042013-06-0680,000— $00SEC↗
BTX BIOTIME INC S Sale2013-06-042013-06-06320,000— $06,620,055SEC↗
BTX BIOTIME INC S Sale2013-03-282013-03-29200,000$3.81 $762.0K7,090,055SEC↗
BTX BIOTIME INC J Other2012-12-142012-12-1857,511$4.34 $249.6K7,110,055SEC↗
BTX BIOTIME INC S Sale2012-11-152012-11-19344,828$2.90 $1.00M7,167,566SEC↗
BTX BIOTIME INC J Other2012-07-302012-07-31140,000$4.77 $667.8K7,512,394SEC↗
BTX BIOTIME INC A Award deriv2012-07-012012-07-0350,000— $050,000SEC↗